ライフサイエンスコーパス: consecutive days

1 usly every 20 min for 23 h each day for 7-10 consecutive days.

2 ter every 20 min for 23 h each day, for 7-10 consecutive days.

3 eter every 20 min for 23 h each day for 7-10 consecutive days.

4 r 3 days as a control period, followed by 10 consecutive days of intravenous ANG II infusion (10 ng k

5 ples were taken every 4h of frying during 10 consecutive days.

6 re meter of body-surface area per day for 10 consecutive days in monthly cycles.

7 aneous corticosterone injection daily for 10 consecutive days in the presence or absence of corticoid

8 n(-1)) in both sham and MnPOx animals for 10 consecutive days, and followed by 3 recovery days.

9 of 7,8-DHF (5 mg/kg, i.p.) once daily for 10 consecutive days.

10 4 hours after infection and continued for 10 consecutive days.

11 ine (control), HDM, or MP twice daily for 10 consecutive days.

12 ed (i.p.) with ERRP (50 microg/mouse) for 10 consecutive days.

13 ater avoidance stress (WA) or sham WA for 10 consecutive days.

14 taneous injections of corticosterone, for 10 consecutive days.

15 th a nose poke response) for 4 h/day, for 10 consecutive days.

16 conspecific, by a male CD1 aggressor, for 10 consecutive days.

17 l or cathodal stimulation for either 5 or 10 consecutive days (500 microA, 15 min).

18 children in Montreal were collected over 10 consecutive days.

19 ts had their ambient air tested for up to 10 consecutive days.

20 n Amb a 1 was instilled intranasally on 1-11 consecutive days, and allergic airway inflammation was e

21 ses of THC (or its vehicle) twice/day for 11 consecutive days (PND 45-55).

22 l, Amb-APE was intranasally instilled for 11 consecutive days.

23 Over 11 consecutive days, these peptides, along with a control p

24 as a daily intravenous bolus infusion for 12 consecutive days in patients with metastatic malignancy.

25 kg per day of IL-15 were administered for 12 consecutive days to patients with metastatic malignant m

26 protein-to-carbohydrate + fat ratio over 12 consecutive days and in relation to age, sex, BMI, and t

27 protein-to-carbohydrate + fat ratios over 12 consecutive days, with beef as a source of protein.

28 pose skin daily to suberythemal doses for 13 consecutive days.

29 aine HCl (approx. 0.5 mg/kg/infusion) for 14 consecutive days (a control group received yoked intrave

30 levels greater than 0.03 U/mL plasma for 14 consecutive days after at least 1 of 4 planned PEG-ASP a

31 -skin contact to 73 premature infants for 14 consecutive days compared with 73 case-matched control s

32 given daily chlorambucil 6 mg/m(2) PO for 14 consecutive days every 28 days for four cycles.

33 21 consecutive days, and 450 mg daily for 14 consecutive days followed by 7 days of no treatment.

34 eight patients received ABX-CBL daily for 14 consecutive days followed by up to 6 weeks of ABX-CBL tw

35 injection (40 mg/kg) of apoEdp daily for 14 consecutive days in an in vivo mouse model of streptozot

36 lled carbon nanotubes for 6 h per day for 14 consecutive days in whole-body inhalation chambers.

37 was given in two divided daily doses for 14 consecutive days of a 21-day cycle for six cycles.

38 of 1% apoEdp topically 4 times a day for 14 consecutive days or intraperitoneal injection (40 mg/kg)

39 plus STS injection (80 mg, once daily for 14 consecutive days).

40 S-1 was administered at 80 mg/m/d for 14 consecutive days, followed by 7 days of rest.

41 S-1 was administered at 80 mg/m/d for 14 consecutive days, followed by 7 days of rest.

42 0 mg/kg/day, the highest dose tested, for 14 consecutive days.

43 kinase (MEK) inhibitor, selumetinib, for 14 consecutive days.

44 latonin (10 mg/body weight) every day for 14 consecutive days.

45 e, and mice were given 10(8) bacteria for 15 consecutive days by gavage.

46 e were exposed to FLX (0 or 20 mg/kg) for 15 consecutive days either during adolescence (postnatal da

47 ose of 10 mg/kg body weight melatonin for 15 consecutive days.

48 nt naive rats were exposed to either 1 or 15 consecutive days (PD35-49) of ketamine (20 mg/kg) twice

49 In 2006, we collected urine samples over 16 consecutive days from children who consumed conventional

50 nd height for 2 consecutive recordings and 2 consecutive days.

51 Exacerbations were diagnosed as 2 consecutive days with one major symptom plus another res

52 The ADYC was responsive to change between 2 consecutive days (Guyatt statistic = 0.77) with a minima

53 P-LTF is evoked by 2 consecutive days of 5-HT applications (2 5-HT), while a

54 ys for lesions on the face or scalp or for 2 consecutive days for the trunk or extremities.

55 en were provided with meals and snacks for 2 consecutive days per week for 4 wk; all foods were consu

56 a level of 120 dB for 3 hours per day for 2 consecutive days produced a significant hearing threshol

57 oximately 30%) in BLI signal intensity for 2 consecutive days, and group 4 (n=5) received ALS after t

58 arge, once delirium-free and coma-free for 2 consecutive days, or after a maximum of 14 days of treat

59 ue, and stress symptoms, 5 times a day for 2 consecutive days, while engaging in usual daily activiti

60 2, or 6 ppm formaldehyde for 6 hr/day for 2 consecutive days.

61 Heat waves were defined as >/= 2 consecutive days with daily mean temperature at or above

62 Of 84,621 patients, 79% received at least 2 consecutive days of antibiotic treatment.

63 ted with relevant antibiotics for at least 2 consecutive days were included in the study.

64 ent was free of organ failure for at least 2 consecutive days, was developed as a new outcome measure

65 his protocol requires about 3 h on each of 2 consecutive days to complete.

66 cose and citrate concentrations on each of 2 consecutive days.Participants included 5 men and 5 women

67 s in cohort 1 were treated with SER-109 on 2 consecutive days (geometric mean dose, 1.7 x 10(9) spore

68 -FeSO4 given at 8:00 am fasting on 1 or on 2 consecutive days (study 1, n = 25; study 2, n = 16); and

69 Patients received 15 capsules on 2 consecutive days and were followed up for symptom resolu

70 On 2 consecutive days before initiation of each study arm, th

71 rospectively with the same imaging unit on 2 consecutive days in 14 patients with rectal cancer (11 m

72 antitumor efficacy of PR-171 delivered on 2 consecutive days is stronger than that of bortezomib adm

73 Seventeen healthy adults were studied on 2 consecutive days on three occasions.

74 same or different sites on the abdomen on 2 consecutive days or by artificial feeding on the skin or

75 eceived 50 mug of rBet v 1 sublingually on 2 consecutive days outside of the birch pollen season.

76 Subjects were challenged on 2 consecutive days with either 4000 pollen grains/m(3) of

77 udy of human volunteers who were tested on 2 consecutive days, a control day and a treatment day.

78 We studied 8 healthy subjects on 2 consecutive days, each of whom participated in three dif

79 Surveys were administered to parents on 2 consecutive days, the day of presentation (when no medic

80 Then, on 2 consecutive days, we fed all infants isotopically labele

81 uring swing using a robotized orthosis) on 2 consecutive days.

82 ncentration and collected stool samples on 2 consecutive days.

83 g estradiol benzoate (EB) in sesame oil on 2 consecutive days.

84 5 microg/kg, administered intravenously on 2 consecutive days.

85 d with a brief application of serotonin on 2 consecutive days.

86 Subjects spent 2 consecutive days each week residing in metabolic chamber

87 severe abdominal discomfort for more than 2 consecutive days including day 10.

88 in 21-day dosing cycles: 50 mg daily for 21 consecutive days, 150 mg daily for 21 consecutive days,

89 for 21 consecutive days, 150 mg daily for 21 consecutive days, and 450 mg daily for 14 consecutive da

90 restraint stress (CRS; 6 hours/day for >/=21 consecutive days) to adult male mice, several hippocampa

91 urine samples were self-collected during 28 consecutive days, and analyzed using an RNA-based NAAT (

92 rates and electrocardiogram intervals for 28 consecutive days without the need to constantly manipula

93 or N-ethyl-N-nitrosourea (ENU), daily for 28 consecutive days, and quantified mtDNA point and deletio

94 ildren with JRA (mean age 8.6 years) over 28 consecutive days using an electronic monitoring device.

95 rague-Dawley rats were subjected to either 3 consecutive days of recurrent moderate (25-40 mg/dl) hyp

96 nificantly reduced in at least 3 sites for 3 consecutive days (days 3 to 5) postchallenge, while sign

97 tial glucose monitoring was undertaken for 3 consecutive days during each intervention, and the ambul

98 as a 1-hour intravenous infusion daily for 3 consecutive days every 21 days, or when hematologic toxi

99 a 25-cm(2) contiguous field once daily for 3 consecutive days for lesions on the face or scalp or for

100 inistered by intraperitoneal injection for 3 consecutive days in rats after laser treatment.

101 sment score greater than or equal to 8 for 3 consecutive days in the first 5 days of intensive care u

102 itabine 20 mg/m(2) intravenously daily for 3 consecutive days on a 28-day cycle.

103 continuous daily dosing and 300 mg bid for 3 consecutive days per week dosing.

104 ethal dose was injected subcutaneously for 3 consecutive days prior to SBI.

105 ality, and five saliva samples per day for 3 consecutive days were collected at baseline, end of trea

106 indicated dosing regimen (40 microg/kg for 3 consecutive days) before chemotherapy was well tolerated

107 er placebo or palifermin (40 microg/kg for 3 consecutive days) before each of two consecutive cycles

108 mg of etoposide per square meter, each for 3 consecutive days, and each followed by an infusion of au

109 platin and 750 mg/m(2) etoposide, each for 3 consecutive days, and each followed by PBSCT.

110 land were sleep deprived (SD) of BSWS for 3 consecutive days, followed by 1 recovery day.

111 ntranasal bFGF-nanoliposomal treatment for 3 consecutive days, functional recovery as indicated by im

112 a 10% lard diet (high fat diet (HFD)) for 3 consecutive days, which is known to induce systemic insu

113 eoxynucleotides (2 microg/day, i.c.v.) for 3 consecutive days.

114 tching placebo with 3-month intervals, for 3 consecutive days.

115 of ideal body weight/day) or IV saline for 3 consecutive days.

116 up to 1 x 10(12)vp intravenously daily for 3 consecutive days.

117 zenehexanamide (MS-PPOH; 20 mg/kg/day) for 3 consecutive days.

118 e, followed by administration of IL-33 for 3 consecutive days.

119 AMPH exposure (1.0 mg/kg once per day for 3 consecutive days; an injection paradigm that has been re

120 012 and received intravenous colistin for >3 consecutive days or died during therapy (termed colistin

121 ting recurrence after NGT removal [for >/= 3 consecutive days in both cases]).

122 during the short-duration tests; however, 3 consecutive days of CTA pairings did produce avoidance o

123 cipated to remain in hospital for at least 3 consecutive days after initial transfusion, were enrolle

124 charge or facial pain lasting for at least 3 consecutive days, or onset of worsening symptoms followi

125 charge or facial pain lasting for at least 3 consecutive days, or worsening symptoms after a typical

126 rmulation of voriconazole for a minimum of 3 consecutive days were included.

127 was applied to 3 skin sites preexposed on 3 consecutive days to 1.9, 3.8, or 7.6 J/cm(2) of solar-si

128 0 h in randomized Latin square of order on 3 consecutive days when measured daily physical activity w

129 ars were negative for acid-fast bacilli on 3 consecutive days) and 22,716 cases of inactive tuberculo

130 challenged with low-dose broadband UVA on 3 consecutive days, and serial biopsies were taken after 6

131 by a lithium chloride (LiCl) injection on 3 consecutive days.

132 thiosemicarbazone) ((61)Cu-ATSM) PET/CT on 3 consecutive days.

133 1900 h in randomized Latin square order on 3 consecutive days.

134 d to nebulized ovalbumin (1% in saline) on 3 consecutive days.

135 subset of 38 subjects was studied on 2 or 3 consecutive days to assess reproducibility.

136 tate gel applied as field therapy for 2 or 3 consecutive days to treat actinic keratoses produced cli

137 Biological variation was determined over 3 consecutive days by using published methods.

138 Following ulnar loading over 3 consecutive days, bone formation parameters were assesse

139 LN5(-/-) (homozygous, affected) sheep over 3 consecutive days, the second day being the sleep depriva

140 ame amount of VR training distributed over 3 consecutive days.

141 (ii) oral hypoglycemic agent use for >/= 30 consecutive days, (iii) insulin therapy for >/= 30 conse

142 utive days, (iii) insulin therapy for >/= 30 consecutive days, and (iv) hemoglobin A1c >/= 6.5%.

143 NA polymerase chain reaction for at least 30 consecutive days.

144 hour intravenous infusion once per day for 4 consecutive days in 22 patients with hematologic maligna

145 designated target lesion once per day for 4 consecutive days on days 1 through 4, 8 through 11, 15 t

146 ally with Alternaria alternata extract for 4 consecutive days to induce ILC2 responses, and these wer

147 ery period, all animals were retrained for 4 consecutive days using the same parameters as during acq

148 p-1(-/-), and asc(-/-) mice once a day for 4 consecutive days.

149 ivation achieved after four laps a day for 4 consecutive days.

150 lp, and upper extremities) twice daily for 4 consecutive days.

151 subsequent urine and feces collection for 4 consecutive days; a separate group of mice was dosed and

152 In a mouse model of 4 consecutive days of airway challenge with an extract of

153 (Dermatophagoides pteronyssinus) powder on 4 consecutive days in an allergen challenge chamber.

154 Anti-CD20 alone, given once or on 4 consecutive days, produced transient B cell depletion bu

155 Self-administration took place on 4 consecutive days/week over 9 months, with a maximum (and

156 four stimulation settings were tested over 4 consecutive days, with stimulation settings held constan

157 eceived ethanol (4.0 g/kg) every 6 h for 3-5 consecutive days via gavage.

158 g/m) started on day -6 and given for 3 and 5 consecutive days, respectively.

159 or 90 min is completely restored following 5 consecutive days of chronic homotypic restraint stress (

160 neous guadecitabine, either once-daily for 5 consecutive days (daily x 5), or once-weekly for 3 weeks

161 notecan given intravenously once daily for 5 consecutive days (DL1: 30 mg/m(2), and DL2: 50 mg/m(2)),

162 saline were administered intravenously for 5 consecutive days (early: d1-3 or delayed: d3-7) to mice

163 travenous imexon over 30 to 45 minutes for 5 consecutive days (one course) every other week (days 1 t

164 Participants wore wristbands for 5 consecutive days and collected first morning void urine

165 minute intravenous infusion once daily for 5 consecutive days every 2 weeks (QDx5) in a 28-day cycle.

166 acebo infusions (n = 44), administered for 5 consecutive days every 3 weeks for up to eight cycles.

167 ere treated with ixabepilone (6 mg/m2) for 5 consecutive days every 3 weeks in a phase II clinical tr

168 dministered as a 2-hour infusion daily for 5 consecutive days for only one cycle on the first four do

169 day, and etoposide 100 mg/m(2) per day for 5 consecutive days in pediatric patients with R/R ALL was

170 isodium was administered at 10 mmol/kg for 5 consecutive days starting after the final dose of CCl(4)

171 ere administered orally with all meals for 5 consecutive days to 7 healthy, free-living adults consum

172 aily, as a 1-hour intravenous infusion for 5 consecutive days, every 21 to 28 days.

173 on of 100 mg/kg of body weight per day for 5 consecutive days, resulted in >84% parasite inhibition a

174 orally administered 1 mg of whole OVA for 5 consecutive days, with control animals receiving PBS.

175 ritoneal route at 15 mg kg(-1) day(-1) for 5 consecutive days.

176 lerated dose (MTD) of 52 mg/m(2) daily for 5 consecutive days.

177 icrog/kg per day of subcutaneous G-CSF for 5 consecutive days.

178 ed by a 4-h sleep opportunity each day for 5 consecutive days.

179 e supernatant was harvested once a day for 5 consecutive days.

180 (CNO) or vehicle injections before each of 5 consecutive days of mating or handling.

181 Home blood pressure was measured on 5 consecutive days at baseline (n = 149) and at 3 and 6 mo

182 tal cortex (DLPFC) (2 mA for 20 minutes on 5 consecutive days).

183 d a novel laparoscopic box-trainer task on 5 consecutive days.

184 olerated when administered for either 2 or 5 consecutive days at doses resulting in >80% proteasome i

185 were moderately to strongly reliable over 5 consecutive days (intraclass correlation coefficients of

186 Subjects practiced over 5 consecutive days while receiving transcranial direct cur

187 Mice were subjected to 5 consecutive days of cocaine or saline followed by a sing

188 l ventilation for greater than or equal to 5 consecutive days were classified as to the presence of a

189 impoverished postweaning environments for 50 consecutive days and then mated and observed with their

190 , tear swabs were collected once daily for 6 consecutive days before treatment.

191 dose of nebulised RPL554 (0.018 mg/kg) for 6 consecutive days in a single-blind (patients masked), pl

192 48 h at a dose of 2 mg/kg or 10 mg/kg for 6 consecutive days starting 24 h after stroke onset.

193 ants, anticonvulsants, or "other") for >/=60 consecutive days in specified doses for those without ot

194 IV positive) were sampled for a median of 64 consecutive days.

195 plication to record all food intake across 7 consecutive days during a participant's regular daily ro

196 Solid gastric emptying was measured after 7 consecutive days of chronic heterotypic stress.

197 ats acquired methamphetamine CPP following 7 consecutive days of conditioning, during which each anim

198 schedule, an attending covered a team for 7 consecutive days and off-service attendings cross-covere

199 al and respiratory data were collected for 7 consecutive days and on the 14 and 28 days.

200 s were then exposed to 7 kHz pure tone for 7 consecutive days and their frequency representations wer

201 d multiwall (MW) CNT (5 mug/g of mice) for 7 consecutive days in a nose-only exposure system.

202 d solid tumors received MLN8054 orally for 7 consecutive days in escalating dose cohorts, with skin a

203 aperitoneally and challenged topically for 7 consecutive days with short ragweed pollen.

204 Cl or meloxicam 3 mg/kg, respectively, for 7 consecutive days.

205 after viral inoculation and continued for 7 consecutive days.

206 MSC-Exo starting at the disease onset for 7 consecutive days.

207 ean AF burden >/=23 hours), persistent (>/=7 consecutive days of AF >/=23 hours/d), paroxysmal (>/=1

208 eater with 1 symptom being severe, on 5 of 7 consecutive days before randomization was required.

209 e every morning and twice every evening on 7 consecutive days, within 15 days of ABPM.

210 e every morning and twice every evening on 7 consecutive days, within 15 days of ABPM.

211 use by urine toxicology or self-report, or 7 consecutive days of self-reported use.

212 We collected spot urine samples over 7 consecutive days from 25 children (3-6 years of age).

213 red with their basal levels collected over 7 consecutive days, suggesting normal hypothalamic-pituita

214 n dosing was not interrupted for more than 7 consecutive days.

215 IL-13 or IL-17 alone or in combination for 8 consecutive days, after which airway hyperresponsiveness

216 e to WT mouse spinal cords with scores for 8 consecutive days.

217 xercise, 2 h after exercise, and daily for 8 consecutive days.

218 Patients missing >/=8 consecutive days of ibrutinib had a shorter median PFS v

219 ulation (thirty 10-pulse 100-Hz trains) on 8 consecutive days, followed by a ninth administration aft

220 ran sodium sulfate to drinking water for 5-9 consecutive days.

221 Administration of AM251 at 3 mg/kg/day for 9 consecutive days also led to a similar reduction ( appro

222 The 24 h urine samples for 9 consecutive days were collected.

223 e or distilled/deionized water vehicle for 9 consecutive days.

224 .2 mg/kg, i.p.) was administered daily for 9 consecutive days.

225 inal loop was exposed to 5 Gy fractions on 9 consecutive days.

226 of race or ethnicity with nonpersistence (90 consecutive days with no claims for a hormonal therapy p

227 ole body illumination 30 min a day for a few consecutive days by near infrared light (830 nm) transmi

228 Five consecutive days of TRNS-accompanied cognitive training

229 stored at different temperatures during five consecutive days without loss of activity.

230 icle control rats on day six, following five consecutive days of exposure.

231 Each dose was given for five consecutive days during which self-administration took p

232 %, 1%, 3% and 5% NaCl) for 100min/d for five consecutive days in eight systems were compared in this

233 y reproducibility of MAI determined for five consecutive days with internal standards was better than

234 ived 10(9) L. plantarum WCFS1 cells for five consecutive days.

235 ected to 60 min of restraint stress for five consecutive days.

236 il, which was heated for 8 h daily over five consecutive days.

237 For consecutive days, samples were collected for assessment

238 Monitoring of Cassiopea pulsing activity for consecutive days and nights revealed behavioral quiescen

239 e dose of Opra Kappa (10 mg p.o. daily, four consecutive days in comparison with an initial baseline

240 eers daily consumed 400 mL of juice for four consecutive days and urine samples were collected before

241 ntraperitoneally with 1.0 mg/kg LPS for four consecutive days to globally activate CNS microglia.

242 rent concentrations of CPT-11 daily for four consecutive days.

243 ale Rowett rats were infected orally on four consecutive days (days 0 to 3) with 1 x 10(9) P. gingiva

244 the motirod for four trials per day on four consecutive days.

245 t at 6 min intervals was collected over four consecutive days at a single wastewater treatment plant.

246 proportions of time spent foraging over four consecutive days post-settlement.

247 epeated systemic challenge of mice over four consecutive days with bacterial LPS maintained an elevat

248 Study procedures occurred over four consecutive days, with working memory testing on Days 1

249 clonidine produced the longest duration (in consecutive days) of abstinence from opioids during the

250 ays to heroin relapse (p=0.009), and maximum consecutive days abstinent (p=0.0007), with all results

251 roin relapse (2.17 [1.38-3.42]), and maximum consecutive days abstinent than with placebo (mean days

252 cutive opioid-positive urine tests), maximum consecutive days of heroin abstinence, and reductions in

253 te a trend for more discrepancies after more consecutive days worked, the difference was not signific

254 t waves were defined as periods of 3 or more consecutive days in which the apparent temperature excee

255 Heat wave periods, defined as 2 or more consecutive days with temperatures exceeding the 99th pe

256 andomly selected from 4859 tweets over 7 non-consecutive days.

257 rence was related inversely to the number of consecutive days of undetectable HCV RNA before transpla

258 re postfire summer weather events (number of consecutive days with high temperatures and no rain) and

259 We defined heat waves as periods of consecutive days with temperatures beyond the 98th perce

260 On consecutive days, erythromycin (200 mg in 20 mL 0.9% sal

261 plus 400 mg of albendazole, administered on consecutive days; oxantel pamoate at a single dose of 20

262 gle- cell stimulation and remain coactive on consecutive days.

263 initiated intraoperatively and continued on consecutive days.

264 al progenitor cells, divided into 3 doses on consecutive days, were delivered into the right atrium v

265 ion of (68)Ga-DOTATOC and (68)Ga-DOTATATE on consecutive days.

266 ion of (68)Ga-DOTATOC and (68)Ga-DOTATATE on consecutive days.

267 nderwent PET with (18)F-FLT and (18)F-FDG on consecutive days.

268 rule-based schema structures during fMRI on consecutive days.

269 move primary cilia and 2 short bouts (2 h on consecutive days) of OFF.

270 p was given 60 mg iron at 0800 h (+/-1 h) on consecutive days for 14 days, and the other group was gi

271 he two measurements of each variable made on consecutive days.

272 an CD4(+) T cells from a proband obtained on consecutive days, we demonstrated the feasibility of ana

273 f (18)F-fluoromethylcholine PET/CT scans, on consecutive days.

274 mental stress myocardial perfusion SPECT on consecutive days.

275 2, and 3 h after injection of each tracer on consecutive days.

276 nts on the postconcussion symptom scale over consecutive days.

277 urden, and effects of high temperatures over consecutive days are similar to what would be experience

278 nonrelapsed (n=44) or relapsed (i.e., seven consecutive days of smoking 1 cigarette/day; n=41).

279 ine was injected intraperitoneally for seven consecutive days to label newly generated cells.

280 d from a wastewater treatment plant in seven consecutive days.

281 d UFP) were measured continuously over seven consecutive days during summer and winter inside 74 home

282 We demonstrated mtDNA detection over seven consecutive days, achieving a limit of detection of 40 c

283 on of the Morris water maze (MWM) over seven consecutive days, and a yawning behavioral test was also

284 nd soluble fractions every 3-4 h for several consecutive days and nights in surface waters from a coa

285 en sleep restriction is repeated for several consecutive days, animals express attenuated compensator

286 ssor or home cage control conditions for six consecutive days and all mice were challenged with C. ro

287 aily directly observed therapy (DOT) for ten consecutive days and then discontinued thereafter.

288 800 h (+/-1 h) and 1700 h (+/-1 h) for three consecutive days.

289 s were completed at bedtime on each of three consecutive days.

290 uble Kato-Katz (KK) faecal slides over three consecutive days for Schistosoma mansoni infection simul

291 t Short Form) once per day over at least two consecutive days using novel test forms each day.

292 A) and challenged with an OVA-aerosol on two consecutive days for 1 week (acute) or 12 weeks (chronic

293 ntly, we observed that pups separated on two consecutive days show an enhanced (sensitized) passive r

294 after, and 20 minutes after lens wear on two consecutive days.

295 neal injections of 1 mg peptidoglycan on two consecutive days.

296 ts was imaged at the same time of day on two consecutive days.

297 e exposed to grass pollen for 3 hours on two consecutive days.

298 r 24-h PM2.5 samples were collected over two consecutive days in each household, with approximately o

299 heta burst stimulation were applied over two consecutive days on the contralesional, left posterior p

300 two study protocols in random order over two consecutive days.